About Biosynex
Biosynex is a company based in Strasbourg (France) founded in 2005.. The company has 486 employees as of December 31, 2024. Biosynex has completed 8 acquisitions, including BigiX Pharma, Bixi Pharma and Chembio. Biosynex offers products and services including Rapid Diagnostic Tests, Ampliflash, and Ampliquick.
- Headquarter Strasbourg, France
- Employees 486 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biosynex Sa
-
Annual Revenue
$105.11 M (USD)8.81as on Dec 31, 2024
-
Net Profit
$-45.02 M (USD)-17.28as on Dec 31, 2024
-
EBITDA
$-70.64 K (USD)99.41as on Dec 31, 2024
-
Latest Funding Round
$1.11 M (USD), Debt – Conventional
Jul 18, 2016
- Investors
-
Employee Count
486
as on Dec 31, 2024
-
Investments & Acquisitions
BigiX Pharma
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Biosynex
Biosynex is a publicly listed company on the EURONEXT with ticker symbol ALBIO in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Biosynex
Biosynex offers a comprehensive portfolio of products and services, including Rapid Diagnostic Tests, Ampliflash, and Ampliquick. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tests for quick detection of medical conditions.
Device for molecular biology testing and analysis.
System for rapid PCR testing in healthcare settings.
Unlock access to complete
Funding Insights of Biosynex
- Total Funding Total Funding
- Total Rounds 2
- Last Round Debt – Conventional — $1.1M
-
First Round
First Round
(06 Nov 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2016 | Amount | Debt – Conventional - Biosynex | Valuation |
investors |
|
| Nov, 2015 | Amount | Post-IPO - Biosynex | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biosynex
Biosynex has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bpifrance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate consultancy, advisory, and funding services are provided to businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biosynex
Biosynex has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include BigiX Pharma, Bixi Pharma and Chembio. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Digital remote health monitoring devices are provided to healthcare providers.
|
2019 | ||||
|
Point-of-care diagnostic devices for immunoassay tests are provided to clinicians.
|
2018 | ||||
|
Manufacturer of half cylinder cushion, antibacterial wedge & sanitizers
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Biosynex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biosynex Comparisons
Competitors of Biosynex
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biosynex
Frequently Asked Questions about Biosynex
When was Biosynex founded?
Biosynex was founded in 2005 and raised its 1st funding round 10 years after it was founded.
Where is Biosynex located?
Biosynex is headquartered in Strasbourg, France. It is registered at Strasbourg, Grand Est, France.
How many employees does Biosynex have?
As of Dec 31, 2024, the latest employee count at Biosynex is 486.
What is the annual revenue of Biosynex?
Annual revenue of Biosynex is $105.11M as on Dec 31, 2024.
What does Biosynex do?
Biosynex (previously DIMA) is the manufacturer and provider of rapid membrane tests in the in-vitro diagnostic market. Its professional diagnostic products include Rapid diagnostic tests (RDTs) to detect an infection (HIV, malaria, mononucleosis, tonsillitis), an immune status (tetanus immunity), a physiological situation (pregnancy), an acute pathological situation (rupture of fetal membranes, myocardial infarction) or the presence of drugs in urine or saliva Blot tests (Western Blot or immunoblot) to indicate the presence or absence of antibodies and Real-time PCR (qPCR) enables the quantitative measure of DNA and ARN molecules. It also develops self-diagnostic tests for pregnancy, drug testing, blood pressure and glucose monitoring. It also provides oral care, reading glasses and foot care products.
What products or services does Biosynex offer?
Biosynex offers Rapid Diagnostic Tests, Ampliflash, and Ampliquick.
Is Biosynex publicly traded?
Yes, Biosynex is publicly traded on EURONEXT under the ticker symbol ALBIO.
How many acquisitions has Biosynex made?
Biosynex has made 8 acquisitions, including BigiX Pharma, Bixi Pharma, and Chembio.
Who are Biosynex's investors?
Biosynex has 1 investor. Key investors include Bpifrance.
What is Biosynex's ticker symbol?
The ticker symbol of Biosynex is ALBIO on EURONEXT.